Ticker brief · 2026-06-22
GH GUARDANT HEALTH INC
Constructive technical leadership offset by short-dated put activity
Consumer, Non-cyclical · Healthcare-Products
Lean: bullishlast close
$167.98
1 day
-1.6%
14 days
+27.5%
mkt cap
$22.3B
signals 14d
49
authors 14d
33
GH skews bullish, with credible growth and technical voices framing it as a healthcare diagnostics leader holding near highs. The late-week shift was bearish options flow on June 16, including aggressive short-dated put buying and a possible moving-average test. Trade structure looks like long exposure is still favored, but near-term entries are being timed around pullbacks rather than chased.
BULL CAMP
Bulls see GH as a high-relative-strength healthcare diagnostics name supported by AI, cancer detection, and aging-demographic themes. The stronger camp is mostly medium to medium-high credibility and includes both thematic and technical support.
Key voices@KeithTradeSmithMEDIUM-HIGHC-0.13@thesetupfactoryMEDIUM-HIGHB+3.19@mark_to_mktMEDIUMC-3.45@RoyLMattoxMEDIUM-HIGHC-1.34
“Healthcare diagnostics basket benefits from AI, cancer detection demand, and aging demographics.”— @KeithTradeSmith · tweet ↗
BEAR / SKEPTIC
Bears are focused on near-term downside rather than a fundamental short thesis, citing aggressive put buying and possible loss of key short-term moving averages.
Key voices@TheMarketBishopLOW-MEDIUMC-2.46@_TP888LOW-MEDIUMC+0.65
“GH could lose the 10-day average and test the 20-day average.”— @TheMarketBishop · tweet ↗
Hypotheses5direction · basis · magnitude · supporters — NEW = first seen this week
▲GH can re-rate as a diagnostics leader benefiting from AI, cancer detection adoption, and aging-demographic healthcare demand.
@KeithTradeSmithMEDIUM-HIGHC-0.131s
▲GH remains a constructive high-relative-strength technical leader near highs, with a potential breakout setup after consolidation.
@thesetupfactoryMEDIUM-HIGHB+3.191s · insight@kkernttbMEDIUM-HIGHC+1.421s@SteveDJacobsMEDIUMC-0.201s@mark_to_mktMEDIUMC-3.452s
▼Aggressive short-dated GH put buying signals near-term downside concern or hedging pressure into the next two days.
@_TP888LOW-MEDIUMC+0.651s@TheMarketBishopLOW-MEDIUMC-2.462s
▼GH risks a short-term technical pullback if it loses the 10-day average and tests the 20-day average.
@TheMarketBishopLOW-MEDIUMC-2.461s
▲Adding GH alongside XBI expresses a bullish biotech exposure call rather than only a standalone company thesis.
@RoyLMattoxMEDIUM-HIGHC-1.341s
Direct calls1authors taking explicit directional positions
@RoyLMattoxMEDIUM-HIGHC-1.34
Added GH and XBI positions while highlighting multiple biotech names as attractive.
News / data points4discrete events + data quoted by authors
@kkernttbMEDIUM-HIGHC+1.42
GH appears among best IBD50 technical setups, though no entry intent is stated.
@SteveDJacobsMEDIUMC-0.20
GH screens as a high-relative-strength stock meeting trend criteria.
@mark_to_mktMEDIUMC-3.45
GH is holding a tight range near highs after a major catalyst.
@TheMarketBishopLOW-MEDIUMC-2.46
Short-dated aggressive put buying appeared in GH.
Position disclosures1skin in the game
@RoyLMattoxMEDIUM-HIGHC-1.34
Added positions in GH and XBI
Desk readconvergence assessment
The view is moderately converged bullish on GH’s leadership and setup, but disagreement is concentrated in timing and near-term risk. Bullish voices carry higher credibility than the bearish flow accounts, while bears are pointing to options activity and technical downside rather than a thesis break. A confirmed loss of short-term moving averages or follow-through in put demand would weaken the bullish setup.
Tracked hypotheses — caliber-scored view · 2026-06-22
🟡 MEDIUM caliber (1)
📈 h2 bull · score 0.37
GH remains a constructive high-relative-strength technical leader near highs, with a potential breakout setup after consolidation.
- Supporters (4): @thesetupfactory↗(MEDIUM-,1p), @kkernttb↗(MEDIUM-,1p), @SteveDJacobs↗(MEDIUM,1p), @marktomkt(MEDIUM,2p)
- Signals: 5 · Max author share: 0.40 · Novelty: building
- Quote: "GH is constructive within a scan of healthcare leaders near highs." — thesetupfactory
🔴 FLAGGED caliber (4)
📈 h5 bull · score 0.09
Adding GH alongside XBI expresses a bullish biotech exposure call rather than only a standalone company thesis.
- Supporters (1): @RoyLMattox↗(MEDIUM-,1p)
- Signals: 1 · Max author share: 1.00 · Novelty: new
- ⚠️ Concentration: 100% from @roylmattox↗ MEDIUM-HIGH cred
- Quote: "Author added GH and XBI while flagging several biotech names as attractive." — RoyLMattox
📈 h1 bull · score 0.08
GH can re-rate as a diagnostics leader benefiting from AI, cancer detection adoption, and aging-demographic healthcare demand.
- Supporters (1): @KeithTradeSmith↗(MEDIUM-,1p)
- Signals: 1 · Max author share: 1.00 · Novelty: new
- ⚠️ Concentration: 100% from @keithtradesmith↗ MEDIUM-HIGH cred
- Quote: "Healthcare diagnostics basket benefits from AI, cancer detection demand, and aging demographics." — KeithTradeSmith
📉 h3 bear · score 0.06
Aggressive short-dated GH put buying signals near-term downside concern or hedging pressure into the next two days.
- Supporters (2): @_TP888↗(LOW-MED,1p), @TheMarketBishop↗(LOW-MED,2p)
- Signals: 3 · Max author share: 0.67 · Novelty: new
- ⚠️ Concentration: 67% from @themarketbishop↗ LOW-MEDIUM cred
- Quote: "Ask-side GH put sweep points to bearish options demand." — _TP888
📉 h4 bear · score 0.02
GH risks a short-term technical pullback if it loses the 10-day average and tests the 20-day average.
- Supporters (1): @TheMarketBishop↗(LOW-MED,1p)
- Signals: 1 · Max author share: 1.00 · Novelty: new
- ⚠️ Concentration: 100% from @themarketbishop↗ LOW-MEDIUM cred
- Quote: "GH could lose the 10-day average and test the 20-day average." — TheMarketBishop
Sentiment — last 14 days
daily mean sentiment, 2026-06-21 → 2026-07-03 · now +0.35 (−1 bearish … +1 bullish)
Who spoke33
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @anandragn | C | -0.52 | 6 | +0.38 |
| @mark_to_mkt | C | -3.45 | 4 | +0.40 |
| @HeidingOut | C | -3.70 | 4 | +0.51 |
| @capestrategico | C | -0.26 | 2 | +0.38 |
| @TamirTiko2110 | C | -2.30 | 2 | +0.60 |
| @AlbertAgarunov | C | +1.62 | 2 | +0.47 |
| @tradergokux | C | -0.46 | 2 | +0.60 |
| @EmmanuelInvest | C | -1.12 | 2 | +0.33 |
| @kkernttb | C | +1.42 | 1 | +0.35 |
| @BullsvsBearMan | C | -2.10 | 1 | +0.45 |
| @IBDinvestors | B | +1.52 | 1 | +0.00 |
| @BottomPhishing | B | -1.87 | 1 | +0.10 |
| @DrStoxx | C | -3.92 | 1 | +0.35 |
| @ivanhoff | C | -0.18 | 1 | +0.35 |
| @NickDrendel | C | +0.19 | 1 | +0.35 |
| @bullishchart | C | +1.98 | 1 | +0.55 |
| @MMMTwealth | A | +1.97 | 1 | +0.00 |
| @Venu_7_ | B | -0.45 | 1 | +0.55 |
| @JSpitTrades | C | +2.63 | 1 | +0.35 |
| @spluscollective | C | -2.80 | 1 | +0.55 |
| @AlexMarenco1 | C | +0.75 | 1 | +0.00 |
| @Ruby_investment | C | -0.54 | 1 | +0.45 |
| @MacroSkokie | C | +0.22 | 1 | +0.70 |
| @cfromhertz | B | +0.07 | 1 | +0.25 |
| @Tautilas | C | -0.63 | 1 | +0.00 |
Recent signals30of 49 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-03 | @AlbertAgarunov | +0.45 | GH shows strong relative strength, new 52-week highs, and breakout/follow-through from basing. | — | tweet ↗ |
| 2026-07-03 | @1ChartMaster | +0.25 | Before-and-after chart recap for GH with no forward intent. | — | tweet ↗ |
| 2026-07-02 | @EmmanuelInvest | +0.40 | Multiple firms remain bullish on Guardant with PTs listed. | — | tweet ↗ |
| 2026-07-02 | @anandragn | +0.35 | Reports past portfolio winners and gains during stealth rotation. | — | tweet ↗ |
| 2026-07-01 | @PrimeTrading_ | +0.20 | Liquid leaders scan sorted by relative strength rank. | -1.6% | tweet ↗ |
| 2026-07-01 | @Volume_Stocks | +0.25 | Lists biggest 52-week high breakouts and says RAAQ up on IQM SPAC merger listing. | -1.6% | tweet ↗ |
| 2026-07-01 | @ConnorJBates_ | +0.25 | AI/memory/semi action is wide and loose while healthcare, biotech, cyber and software led. | -1.6% | tweet ↗ |
| 2026-07-01 | @TWFeditor | +0.35 | Says Q1 was a good time to increase GH stake for fundholders. | -1.6% | tweet ↗ |
| 2026-07-01 | @fundmyfund | +0.25 | Congratulates another user on GH, implying positive move. | -1.6% | tweet ↗ |
| 2026-07-01 | @EmmanuelInvest | +0.25 | Lists stocks hitting new 52-week highs; capped to first six tickers. | -1.6% | tweet ↗ |
| 2026-07-01 | @HeidingOut | +0.45 | Reports GH up 14% today and 36% on new shares. | -1.6% | tweet ↗ |
| 2026-07-01 | @OptionsFlowBoss | +0.55 | Repeated bullish bets detected in GH. | -1.6% | tweet ↗ |
| 2026-07-01 | @HeidingOut | +0.45 | Recaps GH gains: up 8% today, 86% ROI since May, new shares up 28%. | -1.6% | tweet ↗ |
| 2026-07-01 | @tradergokux | +0.65 | Calls GH a textbook breakout case. | -1.6% | tweet ↗ |
| 2026-07-01 | @TamirTiko2110 | +0.80 | Long GH at 150.03 with targets 159.83 and 169.64, stop 143.49. — Explicit live long entry, targets, stop, volume and breakout confirmation. | -1.6% | tweet ↗ |
| 2026-06-29 | @capestrategico | +0.40 | Says GH is unstoppable with chart link. | +9.3% | tweet ↗ |
| 2026-06-28 | @BrandonVanZee | +0.35 | Says many health care charts look glorious and lists tickers. | +12.6% | tweet ↗ |
| 2026-06-27 | @Tautilas | +0.00 | Genomics weekly performance screen sorted by gains. | +12.6% | tweet ↗ |
| 2026-06-26 | @tradergokux | +0.55 | Calls GH a beautiful breakout shared earlier. | +12.6% | tweet ↗ |
| 2026-06-26 | @HeidingOut | +0.50 | Recaps GH hitting $151, up 72% from original call. | +12.6% | tweet ↗ |
| 2026-06-26 | @mark_to_mkt | +0.55 | Says GH looks headed for prior highs and may be long-term compounder. | +12.6% | tweet ↗ |
| 2026-06-26 | @mark_to_mkt | +0.30 | GH showing more follow-through. | +12.6% | tweet ↗ |
| 2026-06-26 | @cfromhertz | +0.25 | Watchlist name moving toward upward VPOC. | +12.6% | tweet ↗ |
| 2026-06-26 | @anandragn | +0.40 | Reports LLY, GH, NTRA, and ILMN making fresh highs. | +12.6% | tweet ↗ |
| 2026-06-26 | @anandragn | +0.40 | Tells readers to find and study LLY and GH, implying positive interest. | +12.6% | tweet ↗ |
| 2026-06-26 | @AlbertAgarunov | +0.50 | GH breakout and follow-through to new 52-week highs in stage 2 advance. | +12.6% | tweet ↗ |
| 2026-06-25 | @MacroSkokie | +0.70 | Discloses long each via calls, common, or both. | +17.5% | tweet ↗ |
| 2026-06-25 | @mark_to_mkt | +0.30 | Nice follow-through. | +17.5% | tweet ↗ |
| 2026-06-25 | @Ruby_investment | +0.45 | Says biotech and diagnostics are coming, listing RVMD, VKTX, NTRA, and GH. | +17.5% | tweet ↗ |
| 2026-06-24 | @AlexMarenco1 | +0.00 | Market recap notes weak session but positive MU earnings reaction and names of note. | +22.6% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.